| 摘要 |
<p>The invention relates to new methods of diagnosis of obesity, in particular morbid obesity, based on the identification of polymorphism in an intron and/or the promoter region of the WAC gene, to method of screening potential obesity therapeutics, to pharmaceutical composition comprising said therapeutics, to transgenic non-human mammal.</p> |
| 申请人 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);FROGUEL, PHILIPPE;DINA, CHRISTIAN;BOUTIN, PHILIPPE;SERON, KARIN;CLEMENT, KARINE |
发明人 |
FROGUEL, PHILIPPE;DINA, CHRISTIAN;BOUTIN, PHILIPPE;SERON, KARIN;CLEMENT, KARINE |
